| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Cbx5 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502613 | 1 kit | ORIGENE TECHNOLOGIES |
| Cbx6 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502614 | 1 kit | ORIGENE TECHNOLOGIES |
| Cbx7 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502615 | 1 kit | ORIGENE TECHNOLOGIES |
| Cbx8 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502616 | 1 kit | ORIGENE TECHNOLOGIES |
| CBX1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305672 | 10 ug | ORIGENE TECHNOLOGIES |
| CBX3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH320388 | 10 ug | ORIGENE TECHNOLOGIES |
| CBX5 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH325208 | 10 ug | ORIGENE TECHNOLOGIES |
| CBX5 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH301515 | 10 ug | ORIGENE TECHNOLOGIES |
| CBX1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH325198 | 10 ug | ORIGENE TECHNOLOGIES |
| Excision repair cross-complementing rodent repair deficiency, complementation group 2 (ERCC2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400141 | 100 ug | ORIGENE TECHNOLOGIES |
| Excision repair cross-complementing rodent repair deficiency, complementation group 2 (ERCC2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427299 | 100 ug | ORIGENE TECHNOLOGIES |
| Excision repair cross-complementing rodent repair deficiency, complementation group 8 (ERCC8), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424939 | 100 ug | ORIGENE TECHNOLOGIES |
| Excision repair cross-complementing rodent repair deficiency, complementation group 8 (ERCC8), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424984 | 100 ug | ORIGENE TECHNOLOGIES |
| Excision repair cross-complementing rodent repair deficiency, complementation group 8 (ERCC8), transcript variant 3 from ORIGENE TECHNOLOGIES | LY423459 | 100 ug | ORIGENE TECHNOLOGIES |
| Excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) (ERCC1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY404356 | 100 ug | ORIGENE TECHNOLOGIES |
| Excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) (ERCC1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY419605 | 100 ug | ORIGENE TECHNOLOGIES |
| Excision repair cross-complementing rodent repair deficiency, complementation group 6-like (ERCC6L) from ORIGENE TECHNOLOGIES | LY413630 | 100 ug | ORIGENE TECHNOLOGIES |
| Excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) (ERCC3) from ORIGENE TECHNOLOGIES | LY424913 | 100 ug | ORIGENE TECHNOLOGIES |
| EXD2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400127 | 1 kit | ORIGENE TECHNOLOGIES |
| EXD1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406223 | 1 kit | ORIGENE TECHNOLOGIES |
| EXD3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN422174 | 1 kit | ORIGENE TECHNOLOGIES |
| Exd1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN505425 | 1 kit | ORIGENE TECHNOLOGIES |
| Exd2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN505426 | 1 kit | ORIGENE TECHNOLOGIES |
| EXD1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH306223 | 10 ug | ORIGENE TECHNOLOGIES |
| EXD3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH322174 | 10 ug | ORIGENE TECHNOLOGIES |
| Human proteasome (prosome, macropain) subunit, beta type, 1 (PSMB1) from ORIGENE TECHNOLOGIES | TP301798 | 20 ug | ORIGENE TECHNOLOGIES |
| Human proteasome (prosome, macropain) subunit, beta type, 2 (PSMB2) from ORIGENE TECHNOLOGIES | TP310452 | 20 ug | ORIGENE TECHNOLOGIES |
| Human proteasome (prosome, macropain) subunit, beta type, 4 (PSMB4) from ORIGENE TECHNOLOGIES | TP305723 | 20 ug | ORIGENE TECHNOLOGIES |
| Human proteasome (prosome, macropain) subunit, beta type, 6 (PSMB6) from ORIGENE TECHNOLOGIES | TP301605 | 20 ug | ORIGENE TECHNOLOGIES |
| Human proteasome (prosome, macropain) subunit, beta type, 7 (PSMB7), full length from ORIGENE TECHNOLOGIES | TP760065 | 50 ug | ORIGENE TECHNOLOGIES |
| Human proteasome (prosome, macropain) subunit, beta type, 5 (PSMB5), transcript variant 1 from ORIGENE TECHNOLOGIES | TP309326 | 20 ug | ORIGENE TECHNOLOGIES |
| Human proteasome maturation protein (POMP) from ORIGENE TECHNOLOGIES | TP304812 | 20 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 17 (ARHGAP17), transcript variant 1 from ORIGENE TECHNOLOGIES | LY423531 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 24 (ARHGAP24), transcript variant 1 from ORIGENE TECHNOLOGIES | LY422457 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 24 (ARHGAP24), transcript variant 3 from ORIGENE TECHNOLOGIES | LY421018 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 24 (ARHGAP24), transcript variant 2 from ORIGENE TECHNOLOGIES | LY410555 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 25 (ARHGAP25), transcript variant 1 from ORIGENE TECHNOLOGIES | LY432336 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 25 (ARHGAP25), transcript variant 2 from ORIGENE TECHNOLOGIES | LY402385 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 25 (ARHGAP25), transcript variant 4 from ORIGENE TECHNOLOGIES | LY431525 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 26 (ARHGAP26), transcript variant 1 from ORIGENE TECHNOLOGIES | LY414809 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 26 (ARHGAP26), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427634 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 27 (ARHGAP27), transcript variant 1 from ORIGENE TECHNOLOGIES | LY404604 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 28 (ARHGAP28), transcript variant 1 from ORIGENE TECHNOLOGIES | LY423177 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 28 (ARHGAP28), transcript variant 2 from ORIGENE TECHNOLOGIES | LY410740 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 30 (ARHGAP30), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405635 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 4 (ARHGAP4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY419816 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 6 (ARHGAP6), transcript variant 4 from ORIGENE TECHNOLOGIES | LY415597 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 8 (ARHGAP8), transcript variant 1 from ORIGENE TECHNOLOGIES | LY422740 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 8 (ARHGAP8), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405790 | 100 ug | ORIGENE TECHNOLOGIES |
| Rho GTPase activating protein 9 (ARHGAP9), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421604 | 100 ug | ORIGENE TECHNOLOGIES |